Wednesday links: invalid inferences

This is an early (and less complete) version of the linkfest. We will back at it tomorrow.

Quote of the day

Jeff Miller, “You cannot make valid inferences from one prior case.”  (A Dash of Insight)

Chart of the day

RAI 1212 624x300 Wednesday links:  invalid inferences

Why are investors so darn calm?  (Businessweek)


Anatomy of a false breakdown.  (The Reformed Broker)

Something has changed in the gold and silver markets.  (Behavioral Macro)

Why insider selling this time of year is no big deal.  (Humble Student of the Markets)

A look at 2013 dividends.  (Political Calculations)

Hedge funds

What stocks drove Tiger Cub performance in 2012.  (II Alpha)

Dan Loeb won big on a bet that Greece would say in the Eurozone.  (FT)


The resurrection of the VelocityShares Daily 2x VIX Short-Term ETNs ($TVIX).  (VIX and More)

An extended look at $XIV vs. $ZIV.  (MarketSci Blog)

Corporate bonds

US corporate credit looks extraordinarily expensive.  (Sober Look)

Putting some numbers on bond interest rate risk.  (FT Alphaville)


The road to mastery for traders.  (Adam Grimes)

How do you avoid concentrated portfolio disasters?  (Above the Market)


Television is the next industry to get destroyed by technology.  (SumZero)

Does Apple ($AAPL) have another iPhone in them?  (SAI)


High frequency trader Getco to buy Knight Capital ($KCG).  (WSJ, Bloomberg, IndexUniverse)

UBS is next up to pay Libor fines.  (MarketBeat, Dealbook, Felix Salmon, FT)

GM ($GM) is buying back shares from the US Treasury.  (Bloomberg)

Nine lessons from this year’s IPO market.  (Wired)


ETF indices matter more for institutions than individuals.  (FT)

Hey look, more dividend ETFs…  (IndexUniverse)


2012 was a good year for “The Corporation.”  (Quartz)

Some not so-good news from the economy in 2012.  (Bonddad Blog)

Some skepticism about shale oil.  (Econbrowser)

Mixed media

Affiliate links are the new display ads.  (Pando Daily)

A winner in the battle of edible bears.  (The Telegraph)

Shocker: antibiotics ‘ineffective for coughs.’  (BBC)

Thanks for checking in with Abnormal Returns. You can follow us on StockTwits and Twitter.

Abnormal Returns is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to If you click on my links and buy anything, even something other than the product advertised, I earn a small commission, yet you don't pay any extra. Thank you for your support.

The information in this blog post represents my own opinions and does not contain a recommendation for any particular security or investment. I or my affiliates may hold positions or other interests in securities mentioned in the Blog, please see my Disclaimer page for my full disclaimer.

blog comments powered by Disqus
  • Tadas ViskantaAbnormal Returns has over its seven-year life become a fixture in the financial blogosphere. Over thousands of posts we have striven to bring the best of the financial blogosphere to readers. In that time the idea of a “forecast-free investment blog” remains as useful as it did six years ago. More »

  • StockTwits Follow Abnormal Returns on StockTwits Follow Abnormal Returns on Twitter Follow StockTwits on Facebook Subscribe to Abnormal Returns RSS via Email Subscribe to Abnormal Returns RSS
  • Recent Posts

  • Archives

  • Join StockTwits
  • Get Updates!

    100% Privacy. We don't spam.